Loading...
Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen sensitivity of prostate cancer cells
We identified the molecular target by histone deacetylase (HDAC) inhibitors for exploring their potential prostate cancer (PCa) therapy. Upon HDAC inhibitors-treatment, LNCaP cell growth was suppressed, correlating with increased cellular prostatic acid phosphatase (cPAcP) expression, an authentic p...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3232184/ https://ncbi.nlm.nih.gov/pubmed/21862211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2011.07.015 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|